• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低线粒体拷贝数的食管鳞状细胞癌具有间充质和干细胞样特征,并导致不良预后。

Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis.

机构信息

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

出版信息

PLoS One. 2018 Feb 15;13(2):e0193159. doi: 10.1371/journal.pone.0193159. eCollection 2018.

DOI:10.1371/journal.pone.0193159
PMID:29447301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5814088/
Abstract

Alterations in mitochondrial DNA (mtDNA) copy numbers in various human cancers have been studied, but any such changes in esophageal squamous cell carcinoma (ESCC) are not established. In the present study, we investigated the correlation of mtDNA copy number with clinicopathologic features, prognosis, and malignant potential of ESCC. MtDNA copy numbers of resected specimens from 80 patients treated with radical esophagectomy were measured by quantitative real-time PCR analyses. Human ESCC cells, TE8 and TE11, were cultured, and depletion of mtDNA content was induced by knockdown of mitochondrial transcription factor A expression or treatment with ethidium bromide. The mRNA and protein expression, proliferation, invasion, and cell cycle were investigated. The results showed that the mtDNA copy number of cancerous portions was 56.0 (37.4-234.5) percent that of non-cancerous parts and significantly lower (p<0.01). Low mtDNA copy number in resected cancerous tissues was significantly correlated with pathological depth of tumor invasion (p = 0.045) and pathological stage (p = 0.025). Patients with lower mtDNA copy number had significantly poorer 5-year overall survival compared to patients with higher levels (p<0.01). The mtDNA-depleted TE8 and TE11 cells had morphological changes and proliferated more slowly than control cells under normoxia but proliferated at almost the same rate under hypoxic conditions. In mtDNA-depleted cells, E-cadherin mRNA expression was decreased, and N-cadherin, vimentin, zeb-1, and cd44 mRNA expression was increased. Immunoblotting and flow cytometry analysis also showed downregulated E-cadherin and upregulated N-cadherin and CD44 protein in mtDNA-depleted cells. Moreover, mtDNA-depleted cells had enhanced invasion, migration, and sphere formation abilities, and the cell cycle arrest at G0/G1 phase was induced in these cells. These results suggested that mtDNA-depleted ESCC cells had mesenchymal characteristics, cancer stemness, and tolerance to hypoxia, which played important role in cancer progression. In conclusion, a low copy number of mtDNA is associated with tumor progression in ESCC.

摘要

线粒体 DNA(mtDNA)拷贝数在各种人类癌症中的改变已经被研究过,但食管癌(ESCC)中是否存在任何此类变化尚未确定。在本研究中,我们调查了 mtDNA 拷贝数与 ESCC 的临床病理特征、预后和恶性潜能的相关性。通过定量实时 PCR 分析测量了 80 例接受根治性食管切除术治疗的患者切除标本中的 mtDNA 拷贝数。培养人 ESCC 细胞 TE8 和 TE11,并通过敲低线粒体转录因子 A 的表达或用溴化乙锭处理来诱导 mtDNA 含量耗竭。研究了 mRNA 和蛋白质表达、增殖、侵袭和细胞周期。结果表明,癌组织部分的 mtDNA 拷贝数为非癌组织部分的 56.0(37.4-234.5)%,显著降低(p<0.01)。切除癌组织中 mtDNA 拷贝数低与肿瘤侵袭的病理深度(p=0.045)和病理分期(p=0.025)显著相关。mtDNA 拷贝数较低的患者与 mtDNA 拷贝数较高的患者相比,5 年总生存率显著降低(p<0.01)。在常氧条件下,mtDNA 耗竭的 TE8 和 TE11 细胞形态发生变化,增殖速度较慢,但在低氧条件下增殖速度几乎相同。在 mtDNA 耗竭的细胞中,E-钙粘蛋白 mRNA 表达减少,而 N-钙粘蛋白、波形蛋白、zeb-1 和 cd44 mRNA 表达增加。免疫印迹和流式细胞术分析也显示 mtDNA 耗竭细胞中 E-钙粘蛋白下调和 N-钙粘蛋白和 CD44 蛋白上调。此外,mtDNA 耗竭细胞的侵袭、迁移和球体形成能力增强,并且这些细胞的细胞周期在 G0/G1 期停滞。这些结果表明,mtDNA 耗竭的 ESCC 细胞具有间充质特征、癌症干性和对缺氧的耐受性,这在癌症进展中发挥了重要作用。总之,mtDNA 低拷贝数与 ESCC 中的肿瘤进展有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/1d0597f2bd46/pone.0193159.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/a20f9a230b16/pone.0193159.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/4c50d76aab7f/pone.0193159.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/1266f7d43ff4/pone.0193159.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/457afd80135b/pone.0193159.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/1d0597f2bd46/pone.0193159.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/a20f9a230b16/pone.0193159.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/4c50d76aab7f/pone.0193159.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/1266f7d43ff4/pone.0193159.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/457afd80135b/pone.0193159.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d78/5814088/1d0597f2bd46/pone.0193159.g005.jpg

相似文献

1
Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis.低线粒体拷贝数的食管鳞状细胞癌具有间充质和干细胞样特征,并导致不良预后。
PLoS One. 2018 Feb 15;13(2):e0193159. doi: 10.1371/journal.pone.0193159. eCollection 2018.
2
Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells.低线粒体 DNA 拷贝数通过 DNA 甲基化诱导食管鳞癌细胞上皮-间充质转化从而诱导化疗耐药。
J Transl Med. 2022 Aug 29;20(1):383. doi: 10.1186/s12967-022-03594-2.
3
High mitochondrial DNA copy number and bioenergetic function are associated with tumor invasion of esophageal squamous cell carcinoma cell lines.高线粒体DNA拷贝数和生物能量功能与食管鳞状细胞癌细胞系的肿瘤侵袭相关。
Int J Mol Sci. 2012;13(9):11228-11246. doi: 10.3390/ijms130911228. Epub 2012 Sep 10.
4
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.高 MLL2 表达通过诱导 EMT 促进食管鳞癌的进展,预示着不良预后。
J Cancer Res Clin Oncol. 2018 Jun;144(6):1025-1035. doi: 10.1007/s00432-018-2625-5. Epub 2018 Mar 12.
5
Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.长链非编码RNA MALAT1的上调促进食管鳞状细胞癌的增殖和转移。
J Exp Clin Cancer Res. 2015 Jan 22;34(1):7. doi: 10.1186/s13046-015-0123-z.
6
Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.抑制SALL4可通过Wnt/β-连环蛋白通路降低食管鳞状细胞癌中涉及上皮-间质转化的致瘤性。
J Exp Clin Cancer Res. 2016 Jun 21;35(1):98. doi: 10.1186/s13046-016-0378-z.
7
PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.PFN2是一种预后不良的新型标志物,是参与食管鳞状细胞癌的潜在治疗靶点。
J Transl Med. 2016 May 17;14(1):137. doi: 10.1186/s12967-016-0884-y.
8
Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.新辅助化疗后行根治性食管切除术治疗的食管鳞状细胞癌中,CD44和CD133作为预后标志物的表达状态。
Oncol Rep. 2016 Dec;36(6):3333-3342. doi: 10.3892/or.2016.5133. Epub 2016 Sep 28.
9
A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma.一种新型长链非编码RNA FOXCUT与mRNA FOXC1配对促进食管鳞状细胞癌进展并预示不良预后。
Int J Clin Exp Pathol. 2014 May 15;7(6):2838-49. eCollection 2014.
10
Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.Cripto-1作为癌症干细胞样细胞的功能标志物,可预测食管鳞状细胞癌患者的预后。
Mol Cancer. 2017 Apr 21;16(1):81. doi: 10.1186/s12943-017-0650-7.

引用本文的文献

1
The Role of Mitochondrial DNA in Modulating Chemoresistance in Esophageal Cancer: Mechanistic Insights and Therapeutic Potential.线粒体DNA在调节食管癌化疗耐药中的作用:机制洞察与治疗潜力
Biomolecules. 2025 Aug 5;15(8):1128. doi: 10.3390/biom15081128.
2
D-loop mutations in mitochondrial DNA are a risk factor for chemotherapy resistance in esophageal cancer.线粒体DNA中的D环突变是食管癌化疗耐药的一个危险因素。
Sci Rep. 2024 Dec 30;14(1):31653. doi: 10.1038/s41598-024-80226-3.
3
Leveraging new methods for comprehensive characterization of mitochondrial DNA in esophageal squamous cell carcinoma.

本文引用的文献

1
Gastroenterological surgery in Japan: The past, the present and the future.日本的胃肠外科手术:过去、现在与未来。
Ann Gastroenterol Surg. 2017 Apr 25;1(1):5-10. doi: 10.1002/ags3.12008. eCollection 2017 Apr.
2
Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinoma.线粒体DNA拷贝数增加预示食管鳞状细胞癌预后不良。
Oncol Lett. 2018 Jan;15(1):1014-1020. doi: 10.3892/ol.2017.7416. Epub 2017 Nov 15.
3
Comprehensive Registry of Esophageal Cancer in Japan, 2010.2010年日本食管癌综合登记处
利用新方法全面分析食管鳞癌中线粒体 DNA 特征。
Genome Med. 2024 Apr 2;16(1):50. doi: 10.1186/s13073-024-01319-2.
4
Mitochondria in Cancer Stem Cells: From an Innocent Bystander to a Central Player in Therapy Resistance.癌症干细胞中的线粒体:从无辜旁观者到治疗抗性的核心角色
Stem Cells Cloning. 2023 Aug 23;16:19-41. doi: 10.2147/SCCAA.S417842. eCollection 2023.
5
Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal Cancer.三阶段新辅助化疗与局部晚期食管癌前两个疗程无应答者的不良生存相关。
Ann Surg Oncol. 2023 Sep;30(9):5899-5907. doi: 10.1245/s10434-023-13548-7. Epub 2023 Jun 14.
6
SP-8356 (A Verbenone Derivative) Inhibits Proliferation, Suppresses Cell Migration and Invasion and Decreases Tumor Growth of Osteosarcoma: Role of PGC-1α/TFAM and AMPK-Activation.SP-8356(一种马鞭草烯酮衍生物)抑制骨肉瘤的增殖、抑制细胞迁移和侵袭并减少肿瘤生长:PGC-1α/TFAM和AMPK激活的作用
Cell J. 2023 May 28;25(5):291-299. doi: 10.22074/cellj.2023.557404.1052.
7
Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells.低线粒体 DNA 拷贝数通过 DNA 甲基化诱导食管鳞癌细胞上皮-间充质转化从而诱导化疗耐药。
J Transl Med. 2022 Aug 29;20(1):383. doi: 10.1186/s12967-022-03594-2.
8
Insights regarding mitochondrial DNA copy number alterations in human cancer (Review).线粒体 DNA 拷贝数改变与人类癌症的相关研究进展(综述)。
Int J Mol Med. 2022 Aug;50(2). doi: 10.3892/ijmm.2022.5160. Epub 2022 Jun 17.
9
Research highlights on contributions of mitochondrial DNA microsatellite instability in solid cancers - an overview.实体癌中线粒体DNA微卫星不稳定性贡献的研究亮点——综述
Contemp Oncol (Pozn). 2022;26(1):8-26. doi: 10.5114/wo.2022.115674. Epub 2022 Mar 30.
10
Mitochondrial genome and its regulator TFAM modulates head and neck tumourigenesis through intracellular metabolic reprogramming and activation of oncogenic effectors.线粒体基因组及其调控因子 TFAM 通过细胞内代谢重编程和激活致癌效应物来调节头颈部肿瘤发生。
Cell Death Dis. 2021 Oct 18;12(11):961. doi: 10.1038/s41419-021-04255-w.
Esophagus. 2017;14(3):189-214. doi: 10.1007/s10388-017-0578-4. Epub 2017 May 19.
4
Cancer adaptations: Atavism, de novo selection, or something in between?癌症适应性:返祖现象、从头选择,还是介于两者之间的某种情况?
Bioessays. 2017 Aug;39(8). doi: 10.1002/bies.201700039. Epub 2017 Jul 10.
5
8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice.美国癌症联合委员会(AJCC)/国际抗癌联盟(UICC)第8版食管癌和食管胃交界癌分期:在临床实践中的应用
Ann Cardiothorac Surg. 2017 Mar;6(2):119-130. doi: 10.21037/acs.2017.03.14.
6
Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer.具有增强转移潜能的癌症干细胞作为食管癌的治疗靶点。
Semin Cancer Biol. 2017 Jun;44:60-66. doi: 10.1016/j.semcancer.2017.03.010. Epub 2017 Mar 30.
7
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.上皮-间质转化(EMT)与癌症干细胞:对胰腺癌治疗耐药性的影响
Mol Cancer. 2017 Feb 28;16(1):52. doi: 10.1186/s12943-017-0624-9.
8
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
9
Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.新辅助化疗后行根治性食管切除术治疗的食管鳞状细胞癌中,CD44和CD133作为预后标志物的表达状态。
Oncol Rep. 2016 Dec;36(6):3333-3342. doi: 10.3892/or.2016.5133. Epub 2016 Sep 28.
10
Role of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma.线粒体DNA拷贝数改变在人类肾细胞癌中的作用
Int J Mol Sci. 2016 May 25;17(6):814. doi: 10.3390/ijms17060814.